Intrexon Corporation (XON) Position Lifted by Pacer Advisors Inc.
Pacer Advisors Inc. boosted its holdings in shares of Intrexon Corporation (NYSE:XON) by 26.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,282 shares of the biotechnology company’s stock after buying an additional 1,930 shares during the period. Pacer Advisors Inc.’s holdings in Intrexon Corporation were worth $224,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its position in Intrexon Corporation by 5.6% during the 1st quarter. Vanguard Group Inc. now owns 4,286,362 shares of the biotechnology company’s stock valued at $84,954,000 after buying an additional 226,090 shares in the last quarter. State Street Corp increased its position in Intrexon Corporation by 34.0% during the 1st quarter. State Street Corp now owns 2,707,242 shares of the biotechnology company’s stock valued at $53,664,000 after buying an additional 687,406 shares in the last quarter. First Trust Advisors LP increased its position in Intrexon Corporation by 32.5% during the 2nd quarter. First Trust Advisors LP now owns 1,537,088 shares of the biotechnology company’s stock valued at $37,028,000 after buying an additional 376,780 shares in the last quarter. Geode Capital Management LLC increased its position in Intrexon Corporation by 3.5% during the 1st quarter. Geode Capital Management LLC now owns 429,532 shares of the biotechnology company’s stock valued at $8,513,000 after buying an additional 14,674 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in Intrexon Corporation by 7.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 234,139 shares of the biotechnology company’s stock valued at $5,640,000 after buying an additional 15,568 shares in the last quarter. 82.27% of the stock is currently owned by institutional investors.
XON has been the topic of a number of research reports. BidaskClub lowered Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Zacks Investment Research lowered Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Finally, Northland Securities set a $30.00 price objective on Intrexon Corporation and gave the company a “buy” rating in a report on Monday, August 7th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $37.60.
In other news, Director Robert B. Shapiro bought 2,850 shares of Intrexon Corporation stock in a transaction dated Tuesday, August 22nd. The stock was acquired at an average cost of $17.50 per share, with a total value of $49,875.00. Following the acquisition, the director now owns 43,157 shares of the company’s stock, valued at $755,247.50. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Andrew J. Last bought 2,000 shares of Intrexon Corporation stock in a transaction dated Monday, August 14th. The stock was purchased at an average cost of $19.99 per share, with a total value of $39,980.00. Following the completion of the acquisition, the chief operating officer now directly owns 2,000 shares in the company, valued at approximately $39,980. The disclosure for this purchase can be found here. Insiders bought a total of 144,569 shares of company stock valued at $2,719,429 over the last three months. Company insiders own 55.10% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This report was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2017/09/16/intrexon-corporation-xon-position-lifted-by-pacer-advisors-inc.html.
Intrexon Corporation (XON) opened at 19.37 on Friday. The stock has a 50 day moving average price of $19.56 and a 200-day moving average price of $21.42. The firm’s market capitalization is $2.33 billion. Intrexon Corporation has a one year low of $17.03 and a one year high of $32.90.
Intrexon Corporation (NYSE:XON) last posted its earnings results on Wednesday, August 9th. The biotechnology company reported ($0.16) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.21) by $0.05. Intrexon Corporation had a negative return on equity of 19.08% and a negative net margin of 60.63%. The business had revenue of $54.40 million during the quarter, compared to the consensus estimate of $57.17 million. During the same period in the previous year, the business earned ($0.42) EPS. The business’s quarterly revenue was up 3.6% on a year-over-year basis. On average, analysts predict that Intrexon Corporation will post ($0.87) earnings per share for the current fiscal year.
About Intrexon Corporation
Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.
Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corporation (NYSE:XON).
Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.